About Sein Medical Technology
Sein Medical Technology Inc. is a Canadian medical technology company dedicated to advancing breast cancer screening through AI, deep learning, and proprietary biomarker science. We're building the tools that will make early detection more accurate, faster, and accessible to every woman globally.
Company Overview
The rising adoption of digital mammography is propelled by its advanced imaging capabilities, particularly its ability to depict low-contrast objects and denser breast tissue more effectively. This shift is fueled by an increasing focus on early detection and screening for breast cancer. Countries across the globe are adopting these advanced systems to capitalize on their superior diagnostic accuracy, ultimately leading to improved patient outcomes.
Sein Medical is poised to meet the rising demand for advanced breast cancer detection and screening through its innovative solution. Our software platform and patented technology integrates AI algorithms, deep learning methods, and biomarker panels to significantly enhance the accuracy and efficiency of mammogram screenings. By leveraging these advanced technologies, we aim to deliver a more reliable and precise screening process, reducing the risks associated with false negatives and false positives.
Our platform is designed for seamless integration into existing healthcare systems, ensuring accessibility to private clinics, individuals, imaging labs, hospitals, and research facilities. We also offer consultation and support services, ensuring smooth implementation and operation. Our solution not only meets but exceeds the market demand for advanced breast cancer detection, providing a cost-effective and easily accessible option for healthcare providers and patients alike.
To save lives by improving mammography screening, enhancing breast cancer detection accuracy, and reducing healthcare costs through improved false-positive rates.
To eradicate breast cancer deaths in women globally by advancing early detection through robust, affordable, and accessible technologies.
Our Values
We leverage the latest advances in AI, deep learning, and biomarker science to build tools that push the boundaries of breast cancer detection.
Every AI-generated analysis includes clear disclaimers and is designed as a decision-support tool, never a replacement for clinical expertise.
Our platform is built around improving patient outcomes through faster, more accurate, and more accessible screening analysis.
All analyses follow the BI-RADS classification system as defined by the American College of Radiology (ACR), ensuring regulatory alignment.
Our Founding Team
Founded by three domain experts who bring together a unique blend of expertise in biomedicine, biophysics, cancer biology, genetic engineering, and biotechnology. Their collective knowledge drives Sein Medical's advancement in the Canadian healthcare industry.
Dr. Minoo Shahani
Founder & Chief Executive Officer
Holds two Ph.D. degrees in Biomedicine (Breast Cancer Biology) and Biophysics. Author of 20+ published papers in breast cancer research. Brings deep domain expertise in cancer biology and drives Sein Medical's scientific vision and product strategy.
LinkedIn
Dorsa Gharagozloo
Chief Clinical Officer
Research assistant in biotechnology and genetics with published top-level papers across multiple research labs. Leads clinical validation, research partnerships, and ensures the platform meets the highest standards of clinical accuracy.
LinkedIn
Dr. Fatemeh Ahmadpour
Chief Operating Officer
Gynecologic oncologist and faculty member at Kish University. Leads research groups and drives Sein Medical's operational expansion in Canada. Brings hands-on clinical experience to ensure the platform serves real-world medical workflows.
LinkedInOur Technology
Our platform integrates multiple cutting-edge technologies into a seamless clinical workflow. The analysis pipeline processes mammogram images through a multi-stage system:
Biomarker Panel Integration
Proprietary biomarker data is combined with imaging analysis for personalized, context-aware screening results.
Deep Learning Vision Analysis
Advanced AI models analyze mammogram images with BI-RADS classification and detailed finding detection.
ACR-Compliant Reporting
Structured reports with clinical impressions, recommendations, and professional PDF generation.
Risk Factor Assessment
Personal history, family history, and genetic markers are integrated into a comprehensive risk score.
Partners & Collaborators
Interested in Working With Us?
Whether you're a healthcare provider, researcher, investor, or potential partner, we'd love to hear from you.
Medical Disclaimer
The Sein Medical AI platform is a decision-support tool designed to assist qualified medical professionals. It does not constitute a medical diagnosis and should not be used as a substitute for professional medical advice, diagnosis, or treatment. All AI-generated analyses must be reviewed and interpreted by a qualified radiologist or physician before any clinical decisions are made.